Evelo: Evelo Biosciences is shutting down according to a regulatory filing
Evelo Biosciences, a biotechnology company launched by Flagship Pioneering to develop microbiome drugs, is shutting down, according to a regulatory filing
Read full article »
President & CEO
Balkrishan Gill
Evelo is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of patients with inflammatory diseases.
Read more